News

Global M&A Insights: Fewer Deals, Bigger Bets Amid Macro Pressure - M&A/Private Equity - Worldwide

H1 2026 just printed USD 2.8 trillion in global M&A — the highest half-year total since H2 2021 — while deal count hit its lowest quarterly mark this decade. Same capital, fewer bets.

Global M&A Insights: Fewer Deals, Bigger Bets Amid Macro Pressure - M&A/Private Equity - Worldwide

H1 2026 just printed USD 2.8 trillion in global M&A — the highest half-year total since H2 2021 — while deal count hit its lowest quarterly mark this decade. Same capital, fewer bets. The market is consolidating exactly the way you'd expect when cost of capital stays elevated and geopolitical risk refuses to resolve.

The math behind "K-shaped"

The headline number obscures a brutal split. Here's the regional breakdown:

  • North America: USD 1.5tn+ — the largest half-year total ever recorded. Volumes still fell 16.2% versus H2 2025, settling at 6,261 transactions.
  • Europe: USD 661.5bn (best since H2 2021). Volume decline was steeper: down 17.8%.
  • Asia Pacific: Moved opposite to the rest of the world. Values dropped 25% to USD 433bn; volumes slid 6% to 8,672 deals.
  • Middle East: USD 45.4bn, up 7% on H2 2025 — despite active regional conflict.

The pattern is consistent: boards are writing fewer, larger checks. Q2 alone produced just 10,309 transactions globally. That's the lowest quarterly count since 2020.

What's driving the mega-deals

Strategic acquirors are doing most of the heavy lifting. Corporates shedding non-core assets under revenue pressure sit across the table from buyers chasing scale to offset macro headwinds. The result: transformational transactions at eye-watering valuations.

Confirmed H1 headline deals include SpaceX's USD 250bn acquisition of xAI, a USD 60bn post-IPO buyout of Anysphere, Paramount Skydance's pending USD 111bn bid for Warner Bros. Discovery, and Devon Energy's USD 58bn merger with Coterra. In the UK, Unilever's foods business combination with McCormick and Ingredion's GBP 2.7bn takeover of Tate & Lyle followed the same logic — flight to quality, strategic fit over financial engineering.

Carve-outs are gaining momentum as a structuring tool. Corporates with sprawling portfolios are finally monetizing divisional assets rather than absorbing restructuring costs internally.

Private equity: active, but constrained

PE firms haven't exited the market. They've changed exit routes. Sponsor-to-sponsor sales and continuation vehicles are replacing IPOs and strategic exits — a sign that assets held for extended periods need recycling, not discovery. Pricing mismatches between buyers and sellers persist. In Europe, investment committees have turned notably cautious on new commitments, per the Mondaq analysis.

The Middle East conflict lengthened deal timelines but didn't kill them. Parties delayed rather than terminated, waiting on the trajectory of U.S.–Iran relations. That patience has a cost: every quarter of delay increases carry drag and refinancing risk on levered positions.

What to track

Three variables will define H2 volume recovery — or further contraction:

1. Interest-rate trajectory. Sticky rates keep debt-financed acquisitions expensive. No relief, no volume rebound.

2. U.S.–Iran conflict resolution. Processes were paused, not cancelled. A ceasefire reopens pipelines.

3. PE exit markets. Continuation vehicles are a patch, not a solution. Sponsors sitting on vintage 2019–2021 funds need real liquidity events by year-end to satisfy LP distributions.

Verdict: Capital is moving — but only toward deals with industrial logic tight enough to justify current pricing. Everything else is on hold.